Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.More than 20 major biopharmaceutical companies, the World Health Organization (WHO), the Wellcome Trust and the European Investment Bank (EIB) have launched the antimicrobial resistance (AMR) Action Fund to help stop the world losing its most powerful tool in healthcare.
This initiative, which is coordinated by trade association the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), has raised nearly $1bn to respond to the AMR threat.
This funding, and technical support from big pharma, will be used to strengthen and accelerate antibiotic development. The WHO predicts that AMR could claim 10.